| | | Single nucleotide variant (3 prime UTR variant +1 more) | Hereditary cancer-predisposing syndrome +2 more | GConflicting classifications of pathogenicity |
| | RAD51L3-RFFL, RAD51D (T328I +2 more) | Single nucleotide variant (missense variant +1 more) | not provided +3 more | GConflicting classifications of pathogenicity |
| | RAD51D, RAD51L3-RFFL (G325S +2 more) | Single nucleotide variant (missense variant +1 more) | Hereditary cancer-predisposing syndrome +4 more | GConflicting classifications of pathogenicity |
| | RAD51L3-RFFL, RAD51D (I311N +2 more) | Single nucleotide variant (missense variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 4 +6 more | GConflicting classifications of pathogenicity |
| | RAD51D, RAD51L3-RFFL (E307K +2 more) | Single nucleotide variant (missense variant +1 more) | not specified +5 more | GConflicting classifications of pathogenicity |
| | RAD51D, RAD51L3-RFFL (G304D +2 more) | Single nucleotide variant (missense variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 4 +3 more | |
| | | Single nucleotide variant (intron variant) | not provided +3 more | GConflicting classifications of pathogenicity |
| | RAD51D, RAD51L3-RFFL (R300* +2 more) | Single nucleotide variant (non-coding transcript variant +1 more) | Hereditary cancer-predisposing syndrome +4 more | GPathogenic/Likely pathogenic |
| | | Single nucleotide variant (non-coding transcript variant +1 more) | Hereditary cancer-predisposing syndrome +2 more | |
| | RAD51D, RAD51L3-RFFL (A293V +2 more) | Single nucleotide variant (non-coding transcript variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 4 +3 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (non-coding transcript variant +1 more) | Hereditary cancer-predisposing syndrome +4 more | |
| | RAD51D, RAD51L3-RFFL (R291H +2 more) | Single nucleotide variant (non-coding transcript variant +1 more) | Hereditary cancer-predisposing syndrome +3 more | |
| | RAD51D, RAD51L3-RFFL (R290W +2 more) | Single nucleotide variant (non-coding transcript variant +1 more) | Hereditary cancer-predisposing syndrome +3 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (non-coding transcript variant +1 more) | not specified +3 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (non-coding transcript variant +1 more) | Hereditary cancer-predisposing syndrome +2 more | |
| | | Single nucleotide variant (non-coding transcript variant +1 more) | Hereditary cancer-predisposing syndrome +2 more | |
| | RAD51D, RAD51L3-RFFL (W268C +2 more) | Single nucleotide variant (non-coding transcript variant +1 more) | Hereditary cancer-predisposing syndrome +1 more | |
| | RAD51D, RAD51L3-RFFL (W268* +2 more) | Single nucleotide variant (non-coding transcript variant +1 more) | not provided +3 more | |
| | RAD51D, RAD51L3-RFFL (W268R +2 more) | Single nucleotide variant (non-coding transcript variant +1 more) | not provided +3 more | |
| | RAD51D, RAD51L3-RFFL (R266H +2 more) | Single nucleotide variant (non-coding transcript variant +1 more) | not provided +3 more | |
| | RAD51D, RAD51L3-RFFL (R266C +2 more) | Single nucleotide variant (non-coding transcript variant +1 more) | not specified +5 more | GConflicting classifications of pathogenicity |
| | RAD51D, RAD51L3-RFFL (G265R +2 more) | Single nucleotide variant (non-coding transcript variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 4 +3 more | |
| | | Single nucleotide variant (non-coding transcript variant +1 more) | Hereditary cancer-predisposing syndrome +3 more | |
| | RAD51D, RAD51L3-RFFL (R239W +2 more) | Single nucleotide variant (non-coding transcript variant +1 more) | Hereditary cancer +3 more | GConflicting classifications of pathogenicity |
| | RAD51D, RAD51L3-RFFL (E233G +2 more) | Single nucleotide variant (non-coding transcript variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 4 +3 more | |
| | RAD51D, RAD51L3-RFFL (R232Q +2 more) | Single nucleotide variant (non-coding transcript variant +1 more) | not specified +4 more | |
| | RAD51D, RAD51L3-RFFL (R232* +2 more) | Single nucleotide variant (nonsense +1 more) | Breast-ovarian cancer, familial, susceptibility to, 4 +5 more | GPathogenic/Likely pathogenic |
| | | Single nucleotide variant (intron variant) | not provided +1 more | |
| | | Single nucleotide variant (non-coding transcript variant +1 more) | not specified +3 more | |
| | RAD51D, RAD51L3-RFFL (A210E +2 more) | Single nucleotide variant (non-coding transcript variant +1 more) | Hereditary cancer-predisposing syndrome +3 more | |
| | RAD51D, RAD51L3-RFFL (A210V +2 more) | Single nucleotide variant (non-coding transcript variant +1 more) | Hereditary breast ovarian cancer syndrome +4 more | |
| | RAD51D, RAD51L3-RFFL (S207L +2 more) | Single nucleotide variant (non-coding transcript variant +1 more) | Hereditary breast ovarian cancer syndrome +4 more | GConflicting classifications of pathogenicity |
| | RAD51D, RAD51L3-RFFL (V203M +2 more) | Single nucleotide variant (non-coding transcript variant +1 more) | Hereditary breast ovarian cancer syndrome +3 more | |
| | | Single nucleotide variant (splice acceptor variant) | Hereditary cancer-predisposing syndrome +3 more | GPathogenic/Likely pathogenic |
| | | Single nucleotide variant (non-coding transcript variant +1 more) | not provided +2 more | GConflicting classifications of pathogenicity |
| | RAD51D, RAD51L3-RFFL (A190T +2 more) | Single nucleotide variant (non-coding transcript variant +1 more) | Hereditary cancer-predisposing syndrome +5 more | GConflicting classifications of pathogenicity |
| | RAD51D, RAD51L3-RFFL (R186* +2 more) | Single nucleotide variant (nonsense +1 more) | Breast-ovarian cancer, familial, susceptibility to, 4 +3 more | |
| | RAD51L3-RFFL, RAD51D (E184K +2 more) | Single nucleotide variant (non-coding transcript variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 4 +3 more | |
| | RAD51D, RAD51L3-RFFL (Q183* +2 more) | Single nucleotide variant (non-coding transcript variant +1 more) | Hereditary cancer-predisposing syndrome +2 more | GPathogenic/Likely pathogenic |
| | RAD51D, RAD51L3-RFFL (A172V +2 more) | Single nucleotide variant (non-coding transcript variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 4 +2 more | |
| | | Single nucleotide variant (non-coding transcript variant +1 more) | not provided +2 more | |
| | RAD51D, RAD51L3-RFFL (R165W +2 more) | Single nucleotide variant (non-coding transcript variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 4 +4 more | |
| | | Single nucleotide variant (intron variant) | Hereditary cancer-predisposing syndrome +3 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (intron variant) | Hereditary cancer-predisposing syndrome +4 more | |
| | RAD51D, RAD51L3-RFFL (E157D +1 more) | Single nucleotide variant (missense variant +2 more) | Hereditary cancer-predisposing syndrome +2 more | |
| | RAD51D, RAD51L3-RFFL (Q151* +1 more) | Single nucleotide variant (nonsense +2 more) | Hereditary breast ovarian cancer syndrome +3 more | GPathogenic/Likely pathogenic |
| | | Single nucleotide variant (synonymous variant +2 more) | not provided +1 more | GConflicting classifications of pathogenicity |
| | RAD51L3-RFFL, RAD51D (R145H +1 more) | Single nucleotide variant (missense variant +2 more) | not provided +2 more | |
| | RAD51D, RAD51L3-RFFL (R145C +1 more) | Single nucleotide variant (missense variant +2 more) | Hereditary cancer-predisposing syndrome +2 more | |
| | RAD51D, RAD51L3-RFFL (S144F +1 more) | Single nucleotide variant (missense variant +2 more) | not provided +4 more | |
| | RAD51D, RAD51L3-RFFL (N138S +1 more) | Single nucleotide variant (missense variant +2 more) | not provided +4 more | GConflicting classifications of pathogenicity |
| | RAD51L3-RFFL, RAD51D (N138D +1 more) | Single nucleotide variant (missense variant +2 more) | not specified +3 more | |
| | RAD51L3-RFFL, RAD51D (N138H +1 more) | Single nucleotide variant (missense variant +2 more) | Breast-ovarian cancer, familial, susceptibility to, 4 +3 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (synonymous variant +2 more) | Hereditary cancer-predisposing syndrome +2 more | GConflicting classifications of pathogenicity |
| | RAD51D, RAD51L3-RFFL (V132I +1 more) | Single nucleotide variant (missense variant +2 more) | Hereditary cancer-predisposing syndrome +3 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (synonymous variant +2 more) | Hereditary cancer-predisposing syndrome +2 more | |
| | RAD51D, RAD51L3-RFFL (A125V +1 more) | Single nucleotide variant (missense variant +2 more) | Hereditary cancer-predisposing syndrome +2 more | |
| | RAD51D, RAD51L3-RFFL (A122fs +1 more) | Deletion (frameshift variant +2 more) | Hereditary breast ovarian cancer syndrome +3 more | GPathogenic/Likely pathogenic |
| | RAD51L3-RFFL, RAD51D (C119Y +1 more) | Single nucleotide variant (missense variant +2 more) | not specified +3 more | |
| | RAD51D, RAD51L3-RFFL (C119R +1 more) | Single nucleotide variant (missense variant +2 more) | Hereditary breast ovarian cancer syndrome +5 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (intron variant) | not provided | |
| | | Single nucleotide variant (intron variant) | not provided +3 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (intron variant) | Breast-ovarian cancer, familial, susceptibility to, 4 +3 more | GConflicting classifications of pathogenicity |
| | RAD51D, RAD51L3-RFFL (G112D +1 more) | Single nucleotide variant (missense variant +2 more) | Hereditary cancer-predisposing syndrome +2 more | |
| | | Single nucleotide variant (synonymous variant +2 more) | Hereditary cancer-predisposing syndrome +2 more | |
| | RAD51D, RAD51L3-RFFL (S111R +1 more) | Single nucleotide variant (missense variant +2 more) | Hereditary cancer-predisposing syndrome +2 more | |
| | RAD51D, RAD51L3-RFFL (G130fs +1 more) | Duplication (frameshift variant +2 more) | not provided +2 more | |
| | RAD51D, RAD51L3-RFFL (T119P +1 more) | Single nucleotide variant (missense variant +2 more) | Breast-ovarian cancer, familial, susceptibility to, 4 +2 more | |
| | | Single nucleotide variant (intron variant) | Breast-ovarian cancer, familial, susceptibility to, 4 +2 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (intron variant) | not provided +3 more | |
| | | Single nucleotide variant (synonymous variant +1 more) | not provided +3 more | |
| | RAD51D, RAD51L3-RFFL (D70Y) | Single nucleotide variant (missense variant +1 more) | not provided | |
| | RAD51D, RAD51L3-RFFL (V66M) | Single nucleotide variant (missense variant +1 more) | not provided +5 more | GConflicting classifications of pathogenicity |
| | RAD51D, RAD51L3-RFFL (P65R) | Single nucleotide variant (missense variant +1 more) | Hereditary cancer-predisposing syndrome +1 more | |
| | RAD51D, RAD51L3-RFFL (A63T) | Single nucleotide variant (missense variant +1 more) | not provided +2 more | |
| | | Single nucleotide variant (synonymous variant +1 more) | Hereditary cancer-predisposing syndrome +2 more | GConflicting classifications of pathogenicity |
| | RAD51D, RAD51L3-RFFL (A49V) | Single nucleotide variant (missense variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 4 +4 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (intron variant) | Breast and/or ovarian cancer +4 more | GConflicting classifications of pathogenicity |
| | RAD51D, RAD51L3-RFFL (S46C) | Single nucleotide variant (missense variant +1 more) | not specified +5 more | GConflicting classifications of pathogenicity |
| | RAD51D, RAD51L3-RFFL (G44D) | Single nucleotide variant (missense variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 4 +3 more | |
| | RAD51D, RAD51L3-RFFL (A34V) | Single nucleotide variant (missense variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 4 +3 more | |
| | RAD51D, RAD51L3-RFFL (V32fs) | Deletion (frameshift variant +1 more) | not provided +2 more | GPathogenic/Likely pathogenic |
| | RAD51D, RAD51L3-RFFL (V28fs) | Deletion (frameshift variant +1 more) | not provided +2 more | GPathogenic/Likely pathogenic |
| | RAD51L3-RFFL, RAD51D (S22R) | Single nucleotide variant (missense variant +1 more) | not provided | |
| | | Single nucleotide variant (synonymous variant +1 more) | not provided +2 more | |
| | RAD51D, RAD51L3-RFFL (Q18R) | Single nucleotide variant (missense variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 4 +3 more | GConflicting classifications of pathogenicity |
| | RAD51D, RAD51L3-RFFL (I17V) | Single nucleotide variant (missense variant +1 more) | not provided +3 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (synonymous variant +1 more) | Hereditary cancer-predisposing syndrome +2 more | |
| | RAD51L3-RFFL, RAD51D (C9S) | Single nucleotide variant (missense variant +1 more) | Hereditary cancer-predisposing syndrome +5 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (synonymous variant +1 more) | Hereditary cancer-predisposing syndrome +3 more | |
| | RAD51D, RAD51L3-RFFL (G2A) | Single nucleotide variant (missense variant +1 more) | Hereditary cancer-predisposing syndrome +2 more | GConflicting classifications of pathogenicity |
| | | Copy number loss | not provided | |
| | | Copy number loss | not provided | |